XFOR (X4 Pharmaceuticals) Forvard P/E multiplikatori
Avtomatlashtirilgan markazlar va yuqori quvvatli zavodlar X4 Pharmaceuticals dori vositalarining uzluksiz ishlab chiqarilishini ta'minlaydi. X4 Pharmaceuticals uchun forward P/E grafigi bozor muvozanati dinamikasini aks ettiradi va qiymat 0.00 darajasida barqarorlashgan. Aksiyalar opsionlari va budjetlar orqali yetakchi tadqiqotchilarni jalb qilish ilmiy salohiyatni mustahkamlaydi, garchi global siyosiy fragmentatsiya va sanksiyalar xalqaro logistikani hamda klinik sinovlar o'tkazishni murakkablashtirsa-da.
X4 Pharmaceuticals kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati X4 Pharmaceuticals|XFOR - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals|XFOR - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar X4 Pharmaceuticals Inc.|XFOR - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari X4 Pharmaceuticals|Shoshilinch likvidlik koeffitsiyenti x4pharma.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
XFOR - Sof daromad|Kutilayotgan sof daromad X4 Pharmaceuticals|XFOR - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati X4 Pharma|XFOR - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati X4 Pharmaceuticals Inc.|XFOR - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) X4 Pharmaceuticals|XFOR - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi x4pharma.com|XFOR - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi X4 Pharmaceuticals
Kompaniyaning jamlanma tahliliyoti:X4 Pharmaceuticals, Inc.
Uzoq muddatli pozitsiyani shakllantirishda, risklarni boshqarish joriy aksiya narxi va kutilayotgan aksiya boshiga foyda nisbatini tahlil qilishni talab qiladi. X4 Pharmaceuticals (XFOR) kompaniyasining kutilayotgan P/E koeffitsiyentini tahlil qilish orqali investor narxga kiritilgan optimizmni baholaydi, bu esa X4 Pharmaceuticals (XFOR) uchun noyob kasalliklar segmentidagi sog'liqni saqlash gigantlarining agressiv bosimi ostida bo'lib, biznesning potentsial narx korreksiyalariga chidamliligini belgilaydi.
X4 Pharmaceuticals (XFOR) raqobatchilari
Prognoz qilingan narxning foydaga nisbati ARGX (argenx)|BNTX (BioNTech Inc.) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (abivax.com)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati ADMA Corp (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|immunovant.com (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols SA|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori Celldex Corp|Kelajakdagi narxning foydaga nisbati Aurinia Pharmaceuticals (AUPH)|biocryst.com - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (Vera Therapeutics)|Dianthus Therapeutics Inc (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS: Prognoz qilingan narxning foydaga nisbati|ABCL (AbCellera Biologics) - Narxning kelajakdagi foydaga nisbati|Narxning kelajakdagi foydaga nisbati Tourmaline Bio, Inc.|Prognoz qilingan narxning foydaga nisbati precigen.com|PHAR - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKTR|UPB - Narxning kutilayotgan foydaga nisbati|Forvard P/E multiplikatori Zenas Corp (ZBIO)|Kelajakdagi narx-foyda multiplikatori Immunome, Inc.|Forvard P/E multiplikatori gossamerbio.com GOSS|KalVista Pharmaceuticals, Inc. - Forvard P/E multiplikatori|SEPN: Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Pieris Pharmaceuticals Inc PVLA|SVRA (Savara Pharma) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati RIGL|Forvard P/E multiplikatori anaptysbio.com|Forvard P/E multiplikatori ATXS|Forvard P/E multiplikatori enGene Holdings Inc (ENGN)|RAPT Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Aerovate Therapeutics, Inc. JBIO|ACRS (Aclaris Therapeutics) - Prognoz qilingan narx-foyda nisbati|kyvernatx.com (KYTX) - Prognoz qilingan narxning foydaga nisbati|TLSA: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Cabaletta Bio Inc.|Ventyx Bio (VTYX) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori Theratechnologies, Inc|AVTX (Avalo Therapeutics, Inc) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori eledon.com (ELDN)|Agenus Inc. - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Climb Bio Inc. CLYM|Zura Bio Limited - Forvard P/E multiplikatori|ATYR: Kelajakdagi narxning foydaga nisbati|adagene.com (ADAG) - Kelajakdagi narxning foydaga nisbati|IMA (Ikena Oncology) - Kelajakdagi narxning foydaga nisbati|STTK: Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Equillium Bio (EQ)|Narxning kelajakdagi foydaga nisbati Connect Biopharma CNTB|Forvard P/E multiplikatori immunic-therapeutics.com (IMUX)|Atara Bio (ATRA) - Narxning kutilayotgan foydaga nisbati|InflaRx NV - Kelajakdagi narxning foydaga nisbati|ACET (Adicet) - Prognoz qilingan narx-foyda nisbati|CELU: Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori INmune Bio Corp INMB|BRNS (Barinthus Biotherapeutics Corp) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati Kezar Life Sciences KZR|Forvard P/E multiplikatori sabbiotherapeutics.com|Akari Therapeutics Plc (AKTX) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori enlivex.com (ENLV)|Forvard P/E multiplikatori QTTB (Q32 Bio)|GeoVax Corp - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Edesa Biotech, Inc. (EDSA)|IBIO: Kelajakdagi narxning foydaga nisbati|CARM (carismatx.com) - Prognoz qilingan narxning foydaga nisbati|XTL Biopharmaceuticals Ltd (XTLB) - Forvard P/E multiplikatori|BOLT (Bolt Biotherapeutics Inc.) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati HCW Biologics Inc (HCWB)|Aptevo Therapeutics (APVO) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori AIM ImmunoTech, Inc. (AIM)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati ADTX|GRI Bio Inc - Kelajakdagi narxning foydaga nisbati|XRTX: Prognoz qilingan narxning foydaga nisbati|HIND: Kelajakdagi narxning foydaga nisbati|REVB (Revelation Biosciences) - Prognoz qilingan narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati indaptusrx.com|SCNI (Scinai Immunotherapeutics Ltd.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati CALI|Narxning kelajakdagi foydaga nisbati Affimed AFMD|Forvard P/E multiplikatori allakos.com (ALLK)|HOOK: Prognoz qilingan narx-foyda nisbati|IGMS - Prognoz qilingan narxning foydaga nisbati|iTeos Therapeutics, Inc. (ITOS) - Narxning kelajakdagi foydaga nisbati|OCEA (Ocean Biomedical Inc) - Narxning kelajakdagi foydaga nisbati|TCBP (TC BioPharm (Holdings) PLC) - Prognoz qilingan narxning foydaga nisbati|Third Harmonic Bio Inc - Kelajakdagi narx-foyda multiplikatori
